A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants
Status:
Recruiting
Trial end date:
2022-09-06
Target enrollment:
Participant gender:
Summary
A study to evaluate safety, tolerability and pharmacokinetics of QLS1128 sustained-release
tablets and in combination with ritonavir tablets in healthy participants